Greenland Mines Ltd. Common Stock (NASDAQ:GRML - Get Free Report) CFO Jeff Leblanc purchased 14,000 shares of Greenland Mines Ltd. Common Stock stock in a transaction that occurred on Tuesday, August 25th. The stock was purchased at an average price of $9.72 per share, with a total value of $136,080.00. Following the transaction, the chief financial officer owned 110,406 shares in the company, valued at $1,073,146.32. This represents a 14.52% increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link.
Greenland Mines Ltd. Common Stock Stock Performance
NASDAQ GRML opened at $9.71 on Wednesday. Greenland Mines Ltd. Common Stock has a twelve month low of $7.81 and a twelve month high of $39.45. The stock has a market cap of $30.88 million, a price-to-earnings ratio of -30.34 and a beta of 7.13. The firm's 50 day moving average price is $10.86 and its two-hundred day moving average price is $17.56.
Greenland Mines Ltd. Common Stock (NASDAQ:GRML - Get Free Report) last announced its earnings results on Monday, August 17th. The company reported ($1.50) earnings per share (EPS) for the quarter.
Key Greenland Mines Ltd. Common Stock News
Here are the key news stories impacting Greenland Mines Ltd. Common Stock this week:
- Positive Sentiment: CFO Jeff Leblanc purchased 14,000 GRML shares for approximately $136,080, increasing his ownership by 14.52%. The insider buying may signal confidence in Greenland Mines’ prospects. SEC insider transaction filing
- Positive Sentiment: A preliminary economic study valued the Sarfartoq Nd-Pr rare-earth project at up to $2.05 billion and estimated a 118.6% pretax internal rate of return. The study covers only the ST1 deposit, leaving potential for further resource growth. Sarfartoq economic study
- Positive Sentiment: An independent S-K 1300 resource estimate identified a high-grade Sarfartoq resource containing valuable magnet rare earths, including neodymium, praseodymium, dysprosium and terbium. The company said contained Nd-Pr oxide is equivalent to roughly five years of non-Chinese refined production in 2025. Sarfartoq mineral resource estimate
- Neutral Sentiment: Reported short interest was zero shares, with a zero-day days-to-cover ratio. The data do not indicate meaningful short-selling pressure, although the reported percentage change was unavailable.
- Neutral Sentiment: Trading was temporarily halted for pending news, increasing volatility and attention around the company’s announcements.
- Negative Sentiment: Greenland Mines announced a proposed public offering of common stock or common-stock equivalents. Because the company has not disclosed the offering size, pricing or terms, investors face uncertainty and potential share dilution. Greenland Mines proposed public offering
- Negative Sentiment: The recently announced 1-for-50 reverse split may improve the trading price and exchange compliance, but it does not change the company’s underlying value and can heighten volatility or signal financing pressure.
Institutional Inflows and Outflows
Several hedge funds have recently bought and sold shares of the company. Brummer Multi Strategy AB bought a new stake in Greenland Mines Ltd. Common Stock in the fourth quarter worth approximately $175,000. Renaissance Technologies LLC acquired a new position in shares of Greenland Mines Ltd. Common Stock during the 4th quarter worth $126,000. Jane Street Group LLC bought a new position in shares of Greenland Mines Ltd. Common Stock during the 4th quarter valued at $64,000. Geode Capital Management LLC raised its holdings in shares of Greenland Mines Ltd. Common Stock by 51.8% during the 4th quarter. Geode Capital Management LLC now owns 491,832 shares of the company's stock valued at $142,000 after purchasing an additional 167,905 shares in the last quarter. Finally, XTX Topco Ltd lifted its stake in shares of Greenland Mines Ltd. Common Stock by 101.2% in the 4th quarter. XTX Topco Ltd now owns 160,569 shares of the company's stock valued at $46,000 after purchasing an additional 80,768 shares during the last quarter. 20.07% of the stock is owned by institutional investors and hedge funds.
Analysts Set New Price Targets
GRML has been the subject of several research analyst reports. Wall Street Zen raised Greenland Mines Ltd. Common Stock to a "sell" rating in a research note on Saturday, May 2nd. Weiss Ratings lowered shares of Greenland Mines Ltd. Common Stock from a "sell (d-)" rating to a "sell (e+)" rating in a research report on Tuesday, August 11th. One research analyst has rated the stock with a Sell rating, According to MarketBeat, the company has an average rating of "Sell".
Get Our Latest Stock Analysis on Greenland Mines Ltd. Common Stock
About Greenland Mines Ltd. Common Stock
(
Get Free Report)
Greenland Mines Ltd develops essential medicines for the treatment of chronic diseases - cancer, cardiovascular, and neurodegenerative disorders. The Company operates as a single reporting segment focused on developing essential medicines for these chronic diseases. The Company has acquired two licensed platforms: a generic drug portfolio and a biosimilar biologics platform that uses biologic therapies to treat cancer, and proprietary patented technologies involving melanocortin receptor-binding molecules and a gene therapy platform that introduces a therapeutic protein called Klotho inside the body to treat neurodegenerative diseases.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
